Justera Health Past Earnings Performance
Past criteria checks 0/6
Justera Health's earnings have been declining at an average annual rate of -26.9%, while the Medical Equipment industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 1.6% per year.
Key information
-26.9%
Earnings growth rate
-4.6%
EPS growth rate
| Medical Equipment Industry Growth | -19.2% |
| Revenue growth rate | 1.6% |
| Return on equity | n/a |
| Net Margin | -65.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Justera Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 5 | -3 | 3 | 0 |
| 30 Jun 23 | 7 | -4 | 4 | 0 |
| 31 Mar 23 | 11 | -6 | 5 | 0 |
| 31 Dec 22 | 15 | -5 | 5 | 0 |
| 30 Sep 22 | 15 | -11 | 5 | 0 |
| 30 Jun 22 | 16 | -8 | 5 | 0 |
| 31 Mar 22 | 17 | -5 | 4 | 0 |
| 31 Dec 21 | 20 | -9 | 4 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Quality Earnings: VTAL is currently unprofitable.
Growing Profit Margin: VTAL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VTAL is unprofitable, and losses have increased over the past 5 years at a rate of 26.9% per year.
Accelerating Growth: Unable to compare VTAL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VTAL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: VTAL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.